Hypogonadism Completed Phase 2 Trials for Clomifene (DB00882)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01880086Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication AdministrationTreatment